MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Management of chronic polyneuropathy associated with levodopa-carbidopa intestinal gel infusion in Parkinson’s disease: Review of the strategies and perspectives

C. Cransac, J. Dupouy, P. Loubiere, B. Ackett, P. Cintas, C. Brefel Courbon, O. Rascol, F. ory Magne (Toulouse, France)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Microelectrode recording for optimization of the long-term outcome in subthalamic deep brain stimulation for Parkinson’s disease

A. Gamaleya, A. Tomskiy, A. Poddubskaya, S. Omarova, A. Dekopov, E. Salova, E. Bril, N. Fedorova (Moscow, Russian Federation)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Mild Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation

A. Troster, A. Abbott, F. Ponce, H. Shill, S. Oravivattanakul, G. Moguel-Cobos, N. Salins, A. Lieberman, K. Hanson (Phoenix, AZ, USA)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Mild to moderate dyskinesia is not significantly related to the level of activity engagement or quality of life of patients with Parkinson’s disease

E. Goubault, S. Bogard, K. Lebel, C. Duval (Montréal, QC, Canada)

Drug-Induced Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Mirthful laughter avoided by directional stimulation in a Parkinson’s disease patient treated with deep brain stimulation

F. Alonso-Frech, M. Monge, C. Fernandez-Garcia, C. Villanueva (MADRID, Spain)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Mitochondrial morphometrics in idiopathic Parkinson‘s disease fibroblasts

P. Antony, O. Boyd, K. Mommaerts, K. Sokolowska, M. Ostaszewski, A. Baumuratov, L. Longhino, F. Poulain, R. Krueger, R. Balling, N. Diederich (Belvaux, Luxembourg)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Modified Frameless Stereotaxy for Gene Therapy in Pediatric Movement Disorder Patients

CH. Tai, SH. Tseng, RM. Wu, WL. Hwu (Taipei, Taiwan)

Therapy in Movement Disorders: Gene and Cell-Based Therapies  ·  Hall 3FG
1:45pm-3:15pm
Molecular immunological action and epigenetic modification of the human papillomavirus vaccination and associated neuropsychiatric side effects

N. Kanzato, K. Nakachi, Y. Takahashi (Okinawa, Japan)

Drug-Induced Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Motor and cognitive progression in GBA-related PD patients submitted to Deep Brain Stimulation

L. Correia Guedes, C. Silva, R. Machado Bouça, N. Gonçalves, M. Fabbri, A. Castro Caldas, P. Pita Lobo, M.M. Rosa, B. Cattoni, H. Carvalho, A. Gonçalves Ferreira, J.J. Ferreira, M. Coelho (Lisbon, Portugal)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of amino acids and monoamine metabolites in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls

F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)

Cognitive Disorders  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 59
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley